【2h】

Stem Cells for Heart Cell Therapies

机译:干细胞用于心脏细胞疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Myocardial infarction–induced heart failure is a prevailing cause of death in the United States and most developed countries. The cardiac tissue has extremely limited regenerative potential, and heart transplantation for reconstituting the function of damaged heart is severely hindered mainly due to the scarcity of donor organs. To that end, stem cells with their extensive proliferative capacity and their ability to differentiate toward functional cardiomyocytes may serve as a renewable cellular source for repairing the damaged myocardium. Here, we review recent studies regarding the cardiogenic potential of adult progenitor cells and embryonic stem cells. Although large strides have been made toward the engineering of cardiac tissues using stem cells, important issues remain to be addressed to enable the translation of such technologies to the clinical setting.
机译:在美国和大多数发达国家,心肌梗死引起的心力衰竭是主要的死亡原因。心脏组织的再生潜能极为有限,并且由于捐赠器官的缺乏,严重阻碍了心脏移植重建受损心脏的功能。为此,具有广泛的增殖能力和向功能性心肌细胞分化的能力的干细胞可以作为修复受损心肌的可再生细胞来源。在这里,我们回顾有关成年祖细胞和胚胎干细胞的心源性潜力的最新研究。尽管在利用干细胞改造心脏组织方面已取得了长足的进步,但是仍然需要解决重要的问题,以使这种技术能够转化为临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号